paclitaxel has been researched along with ginsenoside rg5 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorschel, A; Gopalakrishnan, RM; Ramesh, J; Thilakan, RC; Venugopal, B; Vijayapoopathi, S | 1 |
1 other study(ies) available for paclitaxel and ginsenoside rg5
| Article | Year |
|---|---|
Ginsenoside Rg5 Sensitizes Paclitaxel-Resistant Human Cervical-Adeno-Carcinoma Cells to Paclitaxel-And Enhances the Anticancer Effect of Paclitaxel.
Topics: bcl-2-Associated X Protein; Cell Line, Tumor; Female; Ginsenosides; HeLa Cells; Humans; Paclitaxel; RNA, Messenger; Uterine Cervical Neoplasms | 2022 |